Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines.
Ontology highlight
ABSTRACT: Cancer immunotherapy is currently the hottest topic in the oncology field, owing predominantly to the discovery of immune checkpoint blockers. These promising antibodies and their attractive combinatorial features have initiated the revival of other effective immunotherapies, such as dendritic cell (DC) vaccinations. Although DC-based immunotherapy can induce objective clinical and immunological responses in several tumor types, the immunogenic potential of this monotherapy is still considered suboptimal. Hence, focus should be directed on potentiating its immunogenicity by making step-by-step protocol innovations to obtain next-generation Th1-driving DC vaccines. We review some of the latest developments in the DC vaccination field, with a special emphasis on strategies that are applied t
SUBMITTER: Vandenberk L
PROVIDER: S-EPMC4712296 | biostudies-literature | 2015
REPOSITORIES: biostudies-literature
ACCESS DATA